Can You Take Wegovy for Just One Month — and Does It Work?

The decision: why one month feels tempting but rarely resolves the question

People arrive at this question from different directions. Some have had a difficult few weeks with side effects and want to stop. Some tried a single pen to test the waters and are now weighing up the commitment. Others assumed Wegovy works quickly and are wondering why the scales have barely moved.

All of those are understandable places to be. The honest answer is that one month of Wegovy gives you a tolerability test more than a weight-loss trial. You are almost certainly still on 0.25 mg, the lowest rung of a five-step titration ladder that ends at 2.4 mg (or, now, 7.2 mg following the MHRA's approval of the higher-dose pen in April 2026). A 0.25 mg weekly dose is designed to minimise nausea and vomiting as you start, it is not the dose that appeared in the STEP 1 trial and produced an average 15% body-weight reduction over 68 weeks.

So the decision to take it for only a month is really a decision to stop before treatment has had a fair run. That does not mean it is always the wrong call. It means the decision deserves a proper conversation with a prescriber, not a guess based on week-four results.

What happens to your weight when you stop Wegovy early

A common misconception is that whatever you lose in the first month is yours to keep. In reality, semaglutide works by reducing appetite signals, when the medicine clears your system, those signals return. NHS guidance on semaglutide notes that weight regain after stopping is expected, which is why the prescriber's assessment of how long to continue matters as much as the decision to start.

At month one the dose has likely not yet suppressed appetite enough to drive significant fat loss, so there may not be much to regain. But the pattern holds across all stopping points: short courses tend to produce short-lived results. Clinical trials studied Wegovy over 68 weeks for a reason.

If side effects are the reason you are considering stopping, it is worth raising that with your prescriber before making a final call. Dose adjustments, timing tweaks, and dietary changes can often settle GI symptoms without ending treatment altogether. You can also read more about pausing Wegovy if a temporary break is what you are actually weighing up.

How long does Wegovy need to be taken to see results?

The titration schedule matters here. Starting at 0.25 mg weekly, doses step up roughly every four weeks: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, then 2.4 mg maintenance. That means most people do not reach maintenance until around month five. Results build from there, the 15% average weight reduction seen in the STEP 1 trial was measured at 68 weeks, not at week four.

Early months are not without change. By month two, many people begin to notice appetite suppression more clearly, and some weight loss tends to follow. By month three, the picture is usually clearer still. But asking whether one month is enough is a bit like asking whether a single physio session has fixed a knee, it sets the process in motion, but it is not the finish line.

NICE's recommendation for semaglutide (Wegovy) describes treatment within a managed pathway and notes that if less than 5% weight loss has occurred by six months at the maintenance dose, continuing should be reviewed. That six-month marker gives you a sense of the time horizon clinicians work to.

When stopping at one month might be the right call

There are situations where stopping early is clinically appropriate. Severe or persistent side effects that are not settling. A change in health circumstances that affects suitability. A prescriber's recommendation based on your review. These are all legitimate reasons, and in those cases your prescriber will advise on how to stop safely rather than abruptly.

What is less sound as a reason to stop is disappointment at slow early results, or a plan to restart later without clinical oversight. If cost is part of the calculation, it is worth understanding what a full course of treatment actually includes before concluding that a month is all that is affordable. The cost picture for Wegovy in the UK is more nuanced than a per-pen headline price suggests.

For anyone thinking about a longer trial (three months is a common natural review point) what to expect over three months gives a fuller picture of how results typically develop. And if you want to understand how Wegovy works more broadly before committing to a course, that context is useful to have first. When you are ready to talk through your own situation, our prescribers at nume review consultations the same day, a real clinician reads your case, not a scoring system.